目的：分析有晶状体眼后房型人工晶状体植入术（ICL）对治疗高度近视的临床疗效。 方法：分析2007-09/2011-03行有晶状体眼后房型人工晶状体植入术患者35例70眼。术前常规检查视力、最佳矫正视力，进行各项重要检查后行有晶状体眼后房型人工晶状体植入术。 结果：术后视力0.5~1.0。术后并发症出现白内障1例，一过性眼压升高1例，分别占患者总数的2.9%。白内障行超声乳化手术后视力恢复到1.0，青光眼经治疗后得到控制，视力达到0.8。 结论：有晶状体眼后房型人工晶状体植入术治疗高度近视，特别是超高度近视（＞-12.00D）效果确切。

AIM:To analyse the clinical efficacy of phakic posterior chamber intraocular lens implantation (ICL) for treatment of high myopia. METHODS:Totally 35 patients (70 eyes) (21 males and 14 females, both eyes) with phakic posterior chamber intraocular lens implantation were analysed from September 2007 to March 2011. Routine visual acuity, best-corrected visual acuity and various important examinations were performed preoperatively for phakic posterior chamber intraocular lens implantation. RESULTS:Postoperative visual acuity was 0.5 to 1.0. Postoperative complications had one case of cataract and one case of transient elevation of intraocular pressure, accounted for 2.9% of the total number of patients respectively. After phacoemulsification surgery, visual acuity of cataract recovered to 1.0.Glaucoma was under control after treatment, visual acuity reached 0.8. CONCLUSION:Phakic posterior chamber intraocular lens implantation for high myopia, especially super high myopia (myopia more than 1200) has exact results.